bibliographic entry 3654805 [be/3654805]
https://w3id.org/oc/corpus/be/3654805

is a
content
  • Song, C, Sadashivaiah, K, Furusawa, A, Davila, E, Tamada, K, Banerjee, A. Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy. Oncoimmunology (2014) 3(1): e27680. DOI: 10.4161/onci.27680 PMID: 24790793
references